A continually pretrained 7B Japanese pharmaceutical LLM outperforms open medical models on new Japanese pharma benchmarks, while all models, including GPT-4o, fail at cross-sentence consistency checks.
Title resolution pending
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
cs.CL 1years
2025 1verdicts
CONDITIONAL 1representative citing papers
citing papers explorer
-
A Japanese Language Model and Three New Evaluation Benchmarks for Pharmaceutical NLP
A continually pretrained 7B Japanese pharmaceutical LLM outperforms open medical models on new Japanese pharma benchmarks, while all models, including GPT-4o, fail at cross-sentence consistency checks.